Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risperdal Consta vs Oral Antipsychotics in Poorly Adherent Schizophrenia
NCT00256997Phase 4Terminated
- Sponsor
- Janssen Ortho
- Start
- Jan 2006
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 4 trial of risperidone in schizophrenia, sponsored by Janssen Ortho. Started Jan 2006; status: terminated.
02
Drugs
risperidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00256997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00256997.